PSY59 Variation in Health-Related Quality of Life Associated With Changes in Transfusion Status of Patients With Myelodysplastic Syndromes Across Six Months of Treatment With Azacitidine

Journal article

Open access

Peer reviewed

C.L. Pashos, D.L. Grinblatt, M.A. Sekeres, R.S. Komrokji, M. Narang, A.S. Swern, T.K. Street, K.A. Sullivan, G. Harding and Z.M. Khan

Value in health, Vol.15(4), pp.A109-A109

2012-06

Files and links (1)

url

http://www.valueinhealthjournal.com/article/S1098301512006584/pdfView

Published (Version of record) Open

1 Record Views

This output has contributed to the advancement of the following goals:

Source: InCites

Title: PSY59 Variation in Health-Related Quality of Life Associated With Changes in Transfusion Status of Patients With Myelodysplastic Syndromes Across Six Months of Treatment With Azacitidine
Creators: C.L. Pashos - United BioSource Corporation
D.L. Grinblatt - NorthShore University HealthSystem
M.A. Sekeres - Cleveland Clinic
R.S. Komrokji - Moffitt Cancer Center
M. Narang - Maryland Oncology Hematology
A.S. Swern - Summit
T.K. Street - Summit
K.A. Sullivan - Summit
G. Harding - United BioSource Corporation
Z.M. Khan - Summit
Publication Details: Value in health, Vol.15(4), pp.A109-A109
Publisher: Elsevier Inc
Academic Unit: Miller School of Medicine; UMMG Dept of Medicine - Hematology/Oncology
Language: English
Resource Type: Journal article
Record Identifier: 991031757865002976